Endothelin Receptor Antagonism Improves Lipid Profiles and...

  • Main
  • 2019 / 06
  • Endothelin Receptor Antagonism Improves Lipid Profiles and...
Hypertension 2019 / 06

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease

Farrah, Tariq E., Anand, Atul, Gallacher, Peter J., Kimmitt, Robert, Carter, Edwin, Dear, James W., Mills, Nicholas L., Webb, David J., Dhaun, Neeraj
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Hypertension
DOI:
10.1161/HYPERTENSIONAHA.119.12919
Date:
June, 2019
File:
PDF, 1.06 MB
2019
Conversion to is in progress
Conversion to is failed